CTCs: identified by protein expression of canonical tumor markers (CK+; NKI/beteb+; GFAP+; or chromogranin A + synaptophysin, respectively)CHCs: identified as cells co-positive for a tumor protein and CD45. This evidence concerns the gene PTPRC and neoplasm.